ZIMMER BIOMET HOLDINGS, INC. Accounts Receivable, Allowance for Credit Loss, Current
ZIMMER BIOMET HOLDINGS, INC. (ZBH) had Accounts Receivable, Allowance for Credit Loss, Current of $109.80 million as of 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent · last filed 2026-02-20
- 2025-12-31: Accounts Receivable, Allowance for Credit Loss, Current $109.80M.
- 2024-12-31: Accounts Receivable, Allowance for Credit Loss, Current $93.20M.
- 2023-12-31: Accounts Receivable, Allowance for Credit Loss, Current $75.10M.
- 2022-12-31: Accounts Receivable, Allowance for Credit Loss, Current $78.40M.
| Period end | Accounts Receivable, Allowance for Credit Loss, Current | Accounts Receivable, Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2025-12-31 | $109.80M 10-K · filed 2026-02-20 | |
| 2024-12-31 | $93.20M 10-K · filed 2026-02-20 | |
| 2023-12-31 | $75.10M 10-K · filed 2025-02-25 | |
| 2022-12-31 | $78.40M 8-K · filed 2024-08-07 | |
| 2021-12-31 | $60.10M 10-K · filed 2023-02-24 | $74.60M 10-K · filed 2022-02-25 |
| 2020-12-31 | $58.60M 8-K · filed 2022-06-22 | $75.80M 10-K · filed 2021-02-22 |
| 2020-09-30 | $76.30M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $77.30M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $66.30M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $65.00M 10-K · filed 2021-02-22 | |
| 2018-12-31 | $65.70M 10-K · filed 2020-02-21 | |
| 2017-12-31 | $60.20M 10-K · filed 2019-02-26 | |
| 2016-12-31 | $51.60M 10-K · filed 2018-02-27 | |
| 2015-12-31 | $34.10M 10-K · filed 2017-03-01 | |
| 2014-12-31 | $22.30M 10-K · filed 2016-02-29 | |
| 2013-12-31 | $22.70M 10-K · filed 2015-02-23 | |
| 2012-12-31 | $22.80M 10-K · filed 2014-02-28 | |
| 2011-12-31 | $17.20M 10-K · filed 2013-02-27 | |
| 2010-12-31 | $14.40M 10-K · filed 2012-02-27 | |
| 2009-12-31 | $18.80M 10-K · filed 2011-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |